US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6908757B1
(en)
|
1998-03-26 |
2005-06-21 |
The Procter & Gamble Company |
Serine protease variants having amino acid deletions and substitutions
|
SI1077722T1
(sl)
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
ES2278446T3
(es)
|
1998-05-29 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Vacunas combinadas b/c contra la meningitis.
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
ES2228454T3
(es)
|
1999-02-26 |
2005-04-16 |
Chiron S.R.L. |
Mejora de la actividad bacteriana de antigenos de neisseria con oligonucleotidos que contienen motivos cg.
|
WO2000056360A2
(en)
*
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Vaccine against antigens from bacteriae
|
KR20020007354A
(ko)
|
1999-04-02 |
2002-01-26 |
길리스 스티브 |
폐암의 치료 및 진단에 유용한 화합물 및 방법
|
IL145982A0
(en)
|
1999-04-19 |
2002-07-25 |
Smithkline Beecham Biolog |
Vaccines
|
US6558670B1
(en)
|
1999-04-19 |
2003-05-06 |
Smithkline Beechman Biologicals S.A. |
Vaccine adjuvants
|
EP1171158A2
(en)
*
|
1999-04-20 |
2002-01-16 |
SmithKline Beecham Biologicals s.a. |
Vaccine comprising rsv antigen and cpg oligonucleotide
|
ATE306938T1
(de)
*
|
1999-06-29 |
2005-11-15 |
Glaxosmithkline Biolog Sa |
Verwendung von cpg als adjuvans für hivimpstoff
|
SK782002A3
(en)
*
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
BR0012693A
(pt)
|
1999-07-22 |
2002-04-09 |
Procter & Gamble |
Variante, de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
|
EP1210415A2
(en)
|
1999-07-22 |
2002-06-05 |
The Procter & Gamble Company |
Subtilisin protease variants having amino acid substitutions in defined epitope regions
|
US6946128B1
(en)
|
1999-07-22 |
2005-09-20 |
The Procter & Gamble Company |
Protease conjugates having sterically protected epitope regions
|
KR20020021395A
(ko)
|
1999-07-22 |
2002-03-20 |
데이비드 엠 모이어 |
입체적으로 보호된 clip 부위를 갖는 프로테아제콘쥬게이트
|
EP1204425B1
(en)
|
1999-08-19 |
2009-01-07 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
GB9925559D0
(en)
*
|
1999-10-28 |
1999-12-29 |
Smithkline Beecham Biolog |
Novel method
|
US7223398B1
(en)
|
1999-11-15 |
2007-05-29 |
Dynavax Technologies Corporation |
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
ES2389445T3
(es)
|
2000-02-23 |
2012-10-26 |
Glaxosmithkline Biologicals Sa |
Compuestos novedosos
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20020098199A1
(en)
|
2000-03-10 |
2002-07-25 |
Gary Van Nest |
Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
|
US7157437B2
(en)
|
2000-03-10 |
2007-01-02 |
Dynavax Technologies Corporation |
Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
|
US20010046967A1
(en)
|
2000-03-10 |
2001-11-29 |
Gary Van Nest |
Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
ATE389020T1
(de)
|
2000-04-21 |
2008-03-15 |
Corixa Corp |
Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
|
AUPQ761200A0
(en)
*
|
2000-05-19 |
2000-06-15 |
Hunter Immunology Limited |
Compositions and methods for treatment of mucosal infections
|
DK1284740T3
(da)
|
2000-05-19 |
2008-08-04 |
Corixa Corp |
Profylaktisk og terapeutisk behandling af infektiöse sygdomme, autoimmunsygdomme og allergiske sygdomme med monosaccharidbaserede forbindelser
|
SI1542732T1
(sl)
|
2000-06-20 |
2010-01-29 |
Corixa Corp Csc The United Sta |
Fuzijski proteini Mycobacterium tuberculosis
|
EE200200709A
(et)
|
2000-06-26 |
2004-08-16 |
Stressgen Biotechnologies Corporation |
Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
|
AU2001273149A1
(en)
|
2000-06-28 |
2002-01-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
CN1293192C
(zh)
|
2000-12-27 |
2007-01-03 |
戴纳瓦克斯技术公司 |
免疫调节性多核苷酸及其使用方法
|
CA2446788A1
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
CN100334228C
(zh)
|
2001-06-21 |
2007-08-29 |
戴纳瓦克斯技术公司 |
嵌合免疫调制化合物及其使用方法
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
US20070015721A1
(en)
|
2001-09-20 |
2007-01-18 |
Andrew Beaton |
Hiv-gag codon-optimised dna vaccines
|
EP2224012B1
(en)
|
2001-12-17 |
2013-01-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
CA2388049A1
(en)
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
EP1523557A2
(en)
|
2002-07-24 |
2005-04-20 |
Intercell AG |
Antigens encoded by alternative reading frame from pathogenic viruses
|
EP2402026A3
(en)
|
2002-09-13 |
2012-04-18 |
Intercell AG |
Method for isolating hepatitis C virus peptides
|
US7998492B2
(en)
|
2002-10-29 |
2011-08-16 |
Coley Pharmaceutical Group, Inc. |
Methods and products related to treatment and prevention of hepatitis C virus infection
|
JP2006512927A
(ja)
|
2002-12-11 |
2006-04-20 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
5’cpg核酸およびその使用方法
|
KR100525321B1
(ko)
*
|
2002-12-13 |
2005-11-02 |
안웅식 |
파필로마바이러스 항원 단백질 및CpG-올리고데옥시뉴클레오타이드를 포함하는파필로마바이러스 유발 질환의 예방 또는 치료용 약제학적조성물
|
US8158768B2
(en)
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
WO2004058179A2
(en)
|
2002-12-23 |
2004-07-15 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
RU2389732C2
(ru)
|
2003-01-06 |
2010-05-20 |
Корикса Корпорейшн |
Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
WO2004084938A1
(en)
|
2003-03-24 |
2004-10-07 |
Intercell Ag |
Improved vaccines
|
WO2004084937A1
(en)
*
|
2003-03-24 |
2004-10-07 |
Intercell Ag |
Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses
|
EP1625850B1
(en)
*
|
2003-05-15 |
2012-02-29 |
Japan Science and Technology Agency |
Immunostimulating agents
|
CN1950106A
(zh)
*
|
2003-12-24 |
2007-04-18 |
莱顿大学医学中心 |
用作肿瘤特异性疫苗的合成蛋白质
|
WO2006031264A2
(en)
|
2004-05-25 |
2006-03-23 |
Oregon Health And Science University |
Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors
|
EP3312272B1
(en)
|
2004-10-08 |
2019-08-28 |
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
UA97943C2
(ru)
|
2005-03-31 |
2012-04-10 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Вакцина против инфекции chlamydia
|
DK2457926T3
(da)
|
2005-04-29 |
2015-01-05 |
Glaxosmithkline Biolog Sa |
Ny fremgangsmåde til forebyggelse eller behandling af M. tuberkulose-infektion
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
JP5345053B2
(ja)
*
|
2006-04-19 |
2013-11-20 |
浦項工科大學校 産學協力團 |
子宮頸癌の予防及び治療のためのヒトパピローマウイルスポリペプチドと免疫増強剤を含む組成物
|
CA2659275C
(en)
*
|
2006-07-27 |
2017-01-10 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric influenza virus-like particles
|
EP2044224A4
(en)
*
|
2006-07-27 |
2011-04-13 |
Ligocyte Pharmaceuticals Inc |
CHIMERIC VIRUS TYPE PARTICLES
|
EP3199176B1
(en)
|
2007-04-04 |
2020-02-19 |
Infectious Disease Research Institute |
Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
|
US8518903B2
(en)
|
2007-04-19 |
2013-08-27 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Use of toll-like receptor-9 agonists
|
PE20090146A1
(es)
|
2007-04-20 |
2009-03-23 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica contra el virus influenza
|
EP2148697B1
(en)
|
2007-05-24 |
2012-10-03 |
GlaxoSmithKline Biologicals S.A. |
Lyophilised cpg containing wt-1 composition
|
JP2008308474A
(ja)
*
|
2007-06-18 |
2008-12-25 |
Nitto Denko Corp |
抗原ペプチド製剤の調製方法
|
EP3061462B1
(en)
|
2007-07-02 |
2019-02-27 |
Etubics Corporation |
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
|
KR101811965B1
(ko)
|
2007-11-07 |
2017-12-22 |
셀덱스 쎄라퓨틱스, 인크. |
인간 수지상 및 상피 세포 205(dec-205)에 결합하는 항체
|
PL2222710T3
(pl)
|
2007-12-24 |
2017-01-31 |
Id Biomedical Corporation Of Quebec |
Rekombinowane antygeny rsv
|
WO2010063865A1
(es)
|
2008-12-03 |
2010-06-10 |
Proyecto De Biomedicina Cima, S.L. |
Uso de modulinas solubles en fenol para el desarrollo de vacunas
|
CA2653478A1
(en)
*
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
WO2010125480A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
BRPI1015917A2
(pt)
|
2009-06-24 |
2019-08-27 |
Glaxosmithkline Biologicals Sa |
antígenos de rsv recombinantes.
|
US8889146B2
(en)
|
2009-06-24 |
2014-11-18 |
Glaxosmithkline Biologicals, Sa |
Vaccine
|
HUE058971T2
(hu)
|
2009-07-15 |
2022-09-28 |
Glaxosmithkline Biologicals Sa |
RSV F fehérjekészítmények és eljárások azok elõállítására
|
GB0919117D0
(en)
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
CN102753582A
(zh)
|
2009-11-03 |
2012-10-24 |
莱戈赛特医药股份有限公司 |
嵌合RSV-F多肽、和慢病毒或α-反转录病毒GAG基VLP
|
WO2011101332A1
(en)
|
2010-02-16 |
2011-08-25 |
Proyecto De Biomedicina Cima, S.L. |
Compositions based on the fibronectin extracellular domain a for the treatment of melanoma
|
EA201690310A1
(ru)
|
2010-04-13 |
2016-12-30 |
Селлдекс Терапьютикс Инк. |
Антитела, связывающие cd27 человека, и их применение
|
US9072760B2
(en)
|
2010-09-24 |
2015-07-07 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
|
US10668092B2
(en)
|
2010-09-24 |
2020-06-02 |
The John Hopkins University |
Compositions and methods for treatment of inflammatory disorders
|
WO2012057904A1
(en)
|
2010-10-27 |
2012-05-03 |
Infectious Disease Research Institute |
Mycobacterium tuberculosis antigens and combinations thereof having high seroreactivity
|
WO2012064659A1
(en)
|
2010-11-08 |
2012-05-18 |
Infectious Disease Research Institute |
Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis
|
TWI507413B
(zh)
*
|
2010-11-15 |
2015-11-11 |
Nat Health Research Institutes |
脂質化多抗原表位疫苗
|
CN103260642B
(zh)
|
2010-12-14 |
2018-03-16 |
葛兰素史密丝克莱恩生物有限公司 |
分枝杆菌抗原组合物
|
WO2012088425A2
(en)
|
2010-12-22 |
2012-06-28 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
|
EP2505640A1
(en)
|
2011-03-29 |
2012-10-03 |
Neo Virnatech, S.L. |
Vaccine compositions for birnavirus-borne diseases
|
GB201106357D0
(en)
|
2011-04-14 |
2011-06-01 |
Pessi Antonello |
Composition and uses thereof
|
CN103608030A
(zh)
|
2011-06-21 |
2014-02-26 |
昂科发克特公司 |
用于治疗和诊断癌症的组合物和方法
|
CN102343103B
(zh)
*
|
2011-07-26 |
2016-04-27 |
马丁 |
人乳头状瘤病毒16型三肽疫苗的筛选和验证及持续表达hpv16 e5, e6, e7的肿瘤动物模型的构建
|
EP2666785A1
(en)
|
2012-05-23 |
2013-11-27 |
Affiris AG |
Complement component C5a-based vaccine
|
HUE065746T2
(hu)
|
2012-08-03 |
2024-06-28 |
Access To Advanced Health Inst |
Készítmények és eljárások aktív mycobacterium tuberculosis fertõzés kezelésére
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
WO2014031178A1
(en)
|
2012-08-24 |
2014-02-27 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
EP2703483A1
(en)
|
2012-08-29 |
2014-03-05 |
Affiris AG |
PCSK9 peptide vaccine
|
WO2014052453A1
(en)
*
|
2012-09-25 |
2014-04-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Oral therapy of necrotizing enterocolitis
|
KR20150130438A
(ko)
|
2013-03-12 |
2015-11-23 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 파밀로마 바이러스용 개선된 백신 및 이것을 사용하는 방법
|
DK2970398T3
(da)
|
2013-03-13 |
2024-08-05 |
Us Health |
Præfusions-rsv-f-proteiner og anvendelse deraf
|
UY35418A
(es)
|
2013-03-15 |
2014-10-31 |
Glaxosmithkline Biolog Sa |
Vacuna que proporciona protección frente a diferentes Picornavirus humanos.
|
US9909114B2
(en)
|
2013-03-28 |
2018-03-06 |
Infectious Disease Research Institute |
Vaccines comprising leishmania polypeptides for the treatment and diagnosis of leishmaniasis
|
SG11201600709TA
(en)
|
2013-08-05 |
2016-02-26 |
Glaxosmithkline Biolog Sa |
Combination immunogenic compositions
|
EP2952893A1
(en)
|
2014-06-04 |
2015-12-09 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Method for detecting antibody-secreting B cells specific for HLA
|
US11571472B2
(en)
|
2014-06-13 |
2023-02-07 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations
|
AR102547A1
(es)
|
2014-11-07 |
2017-03-08 |
Takeda Vaccines Inc |
Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
|
AR102548A1
(es)
|
2014-11-07 |
2017-03-08 |
Takeda Vaccines Inc |
Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso
|
KR20230137502A
(ko)
|
2014-12-19 |
2023-10-04 |
레제네상스 비.브이. |
인간 c6에 결합하는 항체 및 이의 용도
|
US11352642B2
(en)
|
2015-01-09 |
2022-06-07 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
WO2016140702A1
(en)
|
2015-03-03 |
2016-09-09 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Serivces |
Display platform from bacterial spore coat proteins
|
EP3268037B1
(en)
|
2015-03-09 |
2022-08-31 |
Celldex Therapeutics, Inc. |
Cd27 agonists
|
US11149087B2
(en)
|
2015-04-20 |
2021-10-19 |
Etubics Corporation |
Methods and compositions for combination immunotherapy
|
MX2017015004A
(es)
|
2015-05-26 |
2018-07-06 |
Ohio State Innovation Foundation |
Estrategia de vacuna basada en nanoparticulas contra el virus de la influenza porcina.
|
CN106543272A
(zh)
*
|
2015-09-18 |
2017-03-29 |
江苏众红生物工程创药研究院有限公司 |
多功能标签融合蛋白及其表达方法和应用
|
US20200377606A1
(en)
|
2016-04-18 |
2020-12-03 |
Celldex Therapeutics, Inc. |
Agonistic antibodies that bind human cd40 and uses thereof
|
MX2018014270A
(es)
|
2016-05-21 |
2019-02-14 |
Infectious Disease Res Inst |
Composiciones y metodos para tratar la tuberculosis secundaria e infecciones po micobacteria no tuberculosa.
|
KR20200138418A
(ko)
|
2016-05-27 |
2020-12-09 |
이투빅스 코포레이션 |
네오에피토프 백신 조성물 및 이의 사용 방법
|
CA3036218A1
(en)
|
2016-09-16 |
2018-03-22 |
Infectious Disease Research Institute |
Vaccines comprising mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy
|
WO2018109220A2
(en)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Novel recombinant prefusion rsv f proteins and uses thereof
|
WO2018162450A1
(en)
|
2017-03-06 |
2018-09-13 |
Fundación Para La Investigación Médica Aplicada |
New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells
|
BR112019021824A2
(pt)
|
2017-04-19 |
2020-06-02 |
Institute For Research In Biomedicine |
Vacinas contra a malária e anticorpos de ligação a esporozoítos de plasmódio
|
MX2019015076A
(es)
|
2017-06-15 |
2020-08-03 |
Infectious Disease Res Inst |
Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos.
|
US11123415B2
(en)
|
2017-08-16 |
2021-09-21 |
Ohio State Innovation Foundation |
Nanoparticle compositions for Salmonella vaccines
|
US11648304B2
(en)
|
2017-11-03 |
2023-05-16 |
Takeda Vaccines, Inc. |
Zika vaccines and immunogenic compositions, and methods of using the same
|
US20210046177A1
(en)
|
2018-01-26 |
2021-02-18 |
Nantcell, Inc. |
Compositions and methods for combination cancer vaccine and immunologic adjuvant therapy
|
MX2020010913A
(es)
|
2018-04-17 |
2021-01-08 |
Celldex Therapeutics Inc |
Anticuerpos anti-cd27 y anti-pd-l1 y constructos biespecíficos.
|
BR112021000529A2
(pt)
|
2018-07-19 |
2021-04-06 |
Glaxosmithkline Biologicals S.A. |
Processos para preparar polissacarídeos secos
|
CN110004150B
(zh)
*
|
2018-08-01 |
2023-03-10 |
中国农业科学院兰州兽医研究所 |
一种具有免疫增强活性的CpG寡聚核苷酸序列及其应用
|
JP7320601B2
(ja)
|
2018-09-11 |
2023-08-03 |
上▲海▼市公共▲衛▼生▲臨▼床中心 |
広域スペクトルな抗インフルエンザワクチン免疫原及びその使用
|
CN109675028A
(zh)
*
|
2019-03-01 |
2019-04-26 |
龙阔(苏州)生物工程有限公司 |
疫苗佐剂及其制备方法和应用及猪繁殖与呼吸综合征疫苗
|
CN109985234A
(zh)
*
|
2019-04-12 |
2019-07-09 |
南华大学 |
一种梅毒螺旋体dna疫苗及其应用
|
US20210220461A1
(en)
*
|
2020-01-17 |
2021-07-22 |
Inventprise, Llc |
Multivalent Streptococcus Vaccines
|
CN114075293B
(zh)
*
|
2020-08-14 |
2022-11-15 |
长沙诺盟生物医药有限公司 |
包含突变的hpv16 e6蛋白的融合蛋白和疫苗组合物
|
US20230310323A1
(en)
|
2020-09-04 |
2023-10-05 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
WO2022217019A1
(en)
|
2021-04-09 |
2022-10-13 |
Celldex Therapeutics, Inc. |
Antibodies against ilt4, bispecific anti-ilt4/pd-l1 antibody and uses thereof
|
WO2023077521A1
(en)
|
2021-11-08 |
2023-05-11 |
Celldex Therapeutics, Inc |
Anti-ilt4 and anti-pd-1 bispecific constructs
|
CN118510790A
(zh)
|
2021-12-13 |
2024-08-16 |
美国政府(由卫生和人类服务部的部长所代表) |
噬菌体λ-疫苗系统
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|
WO2024186635A2
(en)
|
2023-03-03 |
2024-09-12 |
Celldex Therapeutics, Inc. |
Anti-stem cell factor (scf) and anti-thymic stromal lymphopoietin (tslp) antibodies and bispecific constructs
|